drugset / Trial / NCT05444738

Effects of Oxytocin Administered Orally Using a Medicated Lollipop on Peripheral Concentrations and Attention

NCT05444738 ↗

RandomizedParallel-groupTriple-blindBasic science

Summary

The study will investigate whether oxytocin (24IU) administered orally using medicated lollipops results in increased peripheral oxytocin concentrations and can modulate social attention in an anti-saccade paradigm in the same way as when it is administered by intranasal or lingual routes.

Timeline

Start
2022-04-01
Primary completion
2022-07-30
Completion
2022-08-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxytocin Peptide 24 iu Oral

Indications

No indication recorded.